GOLDMAN SACHS GROUP INC - NAUTILUS BIOTECHNOLOGY INC ownership

NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 76 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of NAUTILUS BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$254,968
-30.8%
80,686
-15.2%
0.00%
Q2 2023$368,273
+44.9%
95,161
+3.7%
0.00%
Q1 2023$254,189
+99.4%
91,765
+29.6%
0.00%
Q4 2022$127,467
-19.3%
70,815
-5.0%
0.00%
Q3 2022$158,000
-24.4%
74,567
-4.2%
0.00%
Q2 2022$209,000
-48.5%
77,803
-16.8%
0.00%
Q1 2022$406,000
+35.8%
93,564
+62.2%
0.00%
Q4 2021$299,000
+367.2%
57,676
+453.4%
0.00%
Q3 2021$64,00010,4230.00%
Other shareholders
NAUTILUS BIOTECHNOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Madrona Venture Group, LLC 6,020,770$30,663,0004.08%
Ally Bridge Group (NY) LLC 1,500,000$9,210,0002.71%
AMAZON COM INC 1,457,055$8,946,0001.82%
Affinity Asset Advisors, LLC 975,000$5,987,0001.51%
Tikvah Management LLC 708,540$4,350,436,0001.18%
Perceptive Advisors 8,911,151$54,714,0000.80%
Bain Capital Life Sciences Investors, LLC 2,000,000$12,280,0000.76%
HILLMAN CO 200,000$1,228,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 800,000$4,912,0000.41%
RA Capital Management 2,436,430$14,960,0000.21%
View complete list of NAUTILUS BIOTECHNOLOGY INC shareholders